申请人:Evans Gary Brian
公开号:US20090233948A1
公开(公告)日:2009-09-17
The present invention relates to compounds of the general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5′-methylthioadenosine phosphorylases (MTAP), 5′-methylthioadenosine nucleosidases (MTAN) and/or nucleoside hydrolases (NH). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.
本发明涉及通式(I)的化合物,其为嘌呤核苷酸磷酸酯酶(PNP)、嘌呤磷酸核糖转移酶(PPRT)、5'-甲基硫腺苷磷酸酶(MTAP)、5'-甲基硫腺苷核苷酸酶(MTAN)和/或核苷酸水解酶(NH)的抑制剂。本发明还涉及使用这些化合物治疗包括癌症、细菌感染、原虫感染和T细胞介导疾病在内的疾病和感染,并含有这些化合物的制药组合物。